Table of Content
1 Tumor Genomics Market Introduction and Overview
1.1 Tumor Genomics Introduction
1.2 Research Purposes
1.3 Report Timeline
1.4 Market Size Analysis by Types
1.5 Market Size Analysis by Applications
1.6 Market Size Analysis by Regions
2 Global Market Growth Trends Analysis
2.1 Global Tumor Genomics Market Size & Forecast (2017-2028)
2.2 Tumor Genomics Growth Trends Analysis by Regions
2.2.1 Tumor Genomics Market Size by Regions: 2017 VS 2021 VS 2027
2.2.2 Tumor Genomics Historic Market Share by Regions (2017-2022)
2.2.3 Tumor Genomics Forecasted Market Size by Regions (2023-2028)
3 Global Tumor Genomics Historical and Forecast Market Analysis by Type
3.1 Global Tumor Genomics Revenue and Market Share by Type
3.2 Global Tumor Genomics Market Forecast by Type (2023-2028)
4 Global Tumor Genomics Historical and Forecast Market Analysis by Applications
4.1 Global Tumor Genomics Revenue Market Share by Application (2017-2022)
4.2 Tumor Genomics Market Forecast by Application (2023-2028)
5 North America Tumor Genomics Market analysis
5.1 North America Tumor Genomics Revenue by Type (2017-2028)
5.2 North America Tumor Genomics Revenue by Application (2017-2028)
5.3 North America Tumor Genomics Revenue and Market Share by Countries
5.3.1 North America Tumor Genomics Revenue by Country (2017-2028)
5.3.2 United States Tumor Genomics Revenue and Growth (2017-2028)
5.3.3 Canada Tumor Genomics Revenue and Growth (2017-2028)
5.3.5 Mexico Tumor Genomics Revenue and Growth (2017-2028)
6 Europe Tumor Genomics Market analysis
6.1 Europe Tumor Genomics Revenue by Type (2017-2028)
6.2 Europe Tumor Genomics Revenue by Application (2017-2028)
6.3 Europe Tumor Genomics Revenue and Market Share by Countries
6.3.1 Europe Tumor Genomics Revenue by Country (2017-2028)
6.3.2 Germany Tumor Genomics Market Size and Forecast (2017-2028)
6.3.3 France Tumor Genomics Market Size and Forecast (2017-2028)
6.3.4 United Kingdom Tumor Genomics Market Size and Forecast (2017-2028)
6.3.5 Russia Tumor Genomics Market Size and Forecast (2017-2028)
6.3.6 Italy Tumor Genomics Market Size and Forecast (2017-2028)
7 Asia-Pacific Tumor Genomics Market analysis
7.1 Asia-Pacific Tumor Genomics Revenue by Type (2017-2028)
7.2 Asia-Pacific Tumor Genomics Revenue by Application (2017-2028)
7.3 Asia-Pacific Tumor Genomics Revenue and Market Share by Countries
7.3.1 Asia-Pacific Tumor Genomics Revenue by Country (2017-2028)
7.3.2 China Tumor Genomics Market Size and Forecast (2017-2028)
7.3.3 Japan Tumor Genomics Market Size and Forecast (2017-2028)
7.3.4 South Korea Tumor Genomics Market Size and Forecast (2017-2028)
7.3.5 India Tumor Genomics Market Size and Forecast (2017-2028)
7.3.6 Southeast Asia Tumor Genomics Market Size and Forecast (2017-2028)
7.3.7 Australia Tumor Genomics Market Size and Forecast (2017-2028)
8 Latin America Tumor Genomics Market analysis
8.1 Latin America Tumor Genomics Revenue by Type (2017-2028)
8.2 Latin America Tumor Genomics Revenue by Application (2017-2028)
8.3 Latin America Tumor Genomics Revenue and Market Share by Countries
8.3.1 Latin America Tumor Genomics Revenue by Country (2017-2028)
8.3.2 Brazil Tumor Genomics Market Size and Forecast (2017-2028)
8.3.3 Argentina Tumor Genomics Market Size and Forecast (2017-2028)
9 Middle East & Africa Tumor Genomics Market analysis
9.1 Middle East & Africa Tumor Genomics Revenue by Type (2017-2028)
9.2 Middle East & Africa Tumor Genomics Revenue by Application (2017-2028)
9.3 Middle East & Africa Tumor Genomics Revenue and Market Share by Countries
9.3.1 Middle East & Africa Tumor Genomics Revenue by Country (2017-2028)
9.3.2 Turkey Tumor Genomics Market Size and Forecast (2017-2028)
9.3.3 Saudi Arabia Tumor Genomics Market Size and Forecast (2017-2028)
9.3.4 UAE Tumor Genomics Market Size and Forecast (2017-2028)
10 Tumor Genomics Industry Dynamic Analysis
10.1 Tumor Genomics Market Trends Analysis
10.2 Tumor Genomics Market Drivers Analysis
10.3 Tumor Genomics Market Challenges Analysis
10.4 Tumor Genomics Market Restraints Analysis
10.5 Tumor Genomics Industry Mergers & Acquisitions
10.6 Tumor Genomics Industry New Entrants and Expansion Plans
11 Key Players Analysis
11.1 Global Tumor Genomics Revenue and Market Share Analysis by Key Players
11.2 Global Tumor Genomics Market Concentration Rate Analysis
11.2.1 Top 3 Tumor Genomics Key Players Market Share
11.2.2 Top 6 Tumor Genomics Key Players Market Share

11.3 Abbott Laboratories
11.3.1 Business Overview
11.3.2 Tumor Genomics Major Business
11.3.3 Abbott Laboratories Product and Service Introduction
11.3.4 Abbott Laboratories Tumor Genomics Revenue, Gross Margin and Market Share
11.3.5 Recent Developments and Future Plans
11.4 Agilent Technologies, Inc
11.4.1 Business Overview
11.4.2 Tumor Genomics Major Business
11.4.3 Agilent Technologies, Inc Product and Service Introduction
11.4.4 Agilent Technologies, Inc Tumor Genomics Revenue, Gross Margin and Market Share
11.4.5 Recent Developments and Future Plans
11.5 Bio-Rad Laboratories, Inc.
11.5.1 Business Overview
11.5.2 Tumor Genomics Major Business
11.5.3 Bio-Rad Laboratories, Inc. Product and Service Introduction
11.5.4 Bio-Rad Laboratories, Inc. Tumor Genomics Revenue, Gross Margin and Market Share
11.5.5 Recent Developments and Future Plans
11.6 Danaher Corporation
11.6.1 Business Overview
11.6.2 Tumor Genomics Major Business
11.6.3 Danaher Corporation Product and Service Introduction
11.6.4 Danaher Corporation Tumor Genomics Revenue, Gross Margin and Market Share
11.6.5 Recent Developments and Future Plans
11.7 F. Hoffmann-La Roche Ltd
11.7.1 Business Overview
11.7.2 Tumor Genomics Major Business
11.7.3 F. Hoffmann-La Roche Ltd Product and Service Introduction
11.7.4 F. Hoffmann-La Roche Ltd Tumor Genomics Revenue, Gross Margin and Market Share
11.7.5 Recent Developments and Future Plans
11.8 Fluidigm Corporation
11.8.1 Business Overview
11.8.2 Tumor Genomics Major Business
11.8.3 Fluidigm Corporation Product and Service Introduction
11.8.4 Fluidigm Corporation Tumor Genomics Revenue, Gross Margin and Market Share
11.8.5 Recent Developments and Future Plans
11.9 General Electric Company
11.9.1 Business Overview
11.9.2 Tumor Genomics Major Business
11.9.3 General Electric Company Product and Service Introduction
11.9.4 General Electric Company Tumor Genomics Revenue, Gross Margin and Market Share
11.9.5 Recent Developments and Future Plans
11.10 Illumina, Inc.
11.10.1 Business Overview
11.10.2 Tumor Genomics Major Business
11.10.3 Illumina, Inc. Product and Service Introduction
11.10.4 Illumina, Inc. Tumor Genomics Revenue, Gross Margin and Market Share
11.10.5 Recent Developments and Future Plans
11.11 Merck KGaA
11.11.1 Business Overview
11.11.2 Tumor Genomics Major Business
11.11.3 Merck KGaA Product and Service Introduction
11.11.4 Merck KGaA Tumor Genomics Revenue, Gross Margin and Market Share
11.11.5 Recent Developments and Future Plans
11.12 Myriad Genetics, Inc.
11.12.1 Business Overview
11.12.2 Tumor Genomics Major Business
11.12.3 Myriad Genetics, Inc. Product and Service Introduction
11.12.4 Myriad Genetics, Inc. Tumor Genomics Revenue, Gross Margin and Market Share
11.12.5 Recent Developments and Future Plans
11.13 Pacific Biosciences of California, Inc.
11.13.1 Business Overview
11.13.2 Tumor Genomics Major Business
11.13.3 Pacific Biosciences of California, Inc. Product and Service Introduction
11.13.4 Pacific Biosciences of California, Inc. Tumor Genomics Revenue, Gross Margin and Market Share
11.13.5 Recent Developments and Future Plans
11.14 PerkinElmer
11.14.1 Business Overview
11.14.2 Tumor Genomics Major Business
11.14.3 PerkinElmer Product and Service Introduction
11.14.4 PerkinElmer Tumor Genomics Revenue, Gross Margin and Market Share
11.14.5 Recent Developments and Future Plans
11.15 QIAGEN
11.15.1 Business Overview
11.15.2 Tumor Genomics Major Business
11.15.3 QIAGEN Product and Service Introduction
11.15.4 QIAGEN Tumor Genomics Revenue, Gross Margin and Market Share
11.15.5 Recent Developments and Future Plans
11.16 Siemens Healthineers AG
11.16.1 Business Overview
11.16.2 Tumor Genomics Major Business
11.16.3 Siemens Healthineers AG Product and Service Introduction
11.16.4 Siemens Healthineers AG Tumor Genomics Revenue, Gross Margin and Market Share
11.16.5 Recent Developments and Future Plans
11.17 Thermo Fisher Scientific Inc.
11.17.1 Business Overview
11.17.2 Tumor Genomics Major Business
11.17.3 Thermo Fisher Scientific Inc. Product and Service Introduction
11.17.4 Thermo Fisher Scientific Inc. Tumor Genomics Revenue, Gross Margin and Market Share
11.17.5 Recent Developments and Future Plans
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.2.3 Legal Disclaimer